[Nivaline therapy in residual hemiparesis from cerebral vascular disorders].
D000924:Anticholesteremic Agents; D002561:Cerebrovascular Disorders / Q000150:complications*; D005702:Galantamine; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000628:therapy*; D010243:Paralysis / Q000628:therapy*; D010291:Paresis
D000924:Anticholesteremic Agents; D005702:Galantamine
CEREBRAL ARTERIOSCLEROSIS/therapy; CEREBROVASCULAR DISORDERS/complications; CHOLESTEROL/antagonists; PARALYSIS/therapy